SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?


To: Pseudo Biologist who wrote (5192)6/29/1998 1:46:00 PM
From: Mr. Sam  Respond to of 9719
 
PB, Thanks for the well-researched response to my query about GenVec. On CNBC, Robert Langreth, the medical reporter for the Wall Street Journal, just mentioned GenVec, Collateral Therapeutics, and Vascular Genetics as the leaders in angiogenesis since Genentech got this area of research kicked off. I've done additional research since reading your response and have decided to invest in GenVec when it goes public this week. Thanks again for the help.

Mr. Sam